Cardiol Therapeutics

+$0.08 (+7.34%) Today
+$0.01 (+0.85%) As of 9:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDL and other ETFs, options, and stocks.

About CRDL

Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on developing anti-inflammatory therapies for cardiovascular disease (CVD). Their lead product, CardiolRx, is a pharmaceutical manufactured cannabidiol formulation being investigated in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for CVD.

CEO
David G. Elsley
Employees
19
Headquarters
Oakville, Ontario
Founded
2017

CRDL Key Statistics

Market cap
72.45M
Price-Earnings ratio
—
Dividend yield
—
Average volume
197.82K
High today
$1.18
Low today
$1.07
Open price
$1.08
Volume
110.70K
52 Week high
$4.96
52 Week low
$1.00

CRDL Earnings

-$0.23
-$0.15
-$0.08
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected May 31, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure